UK +44 (0)1865 849841
Malaysia +603 2779 0098

Tag: microbiome futures

A personal translation of Microbiome Futures

It was a pleasure to have Dirk Gevers involved in our Microbiome Futures project earlier this year. In the following opinion piece, Dirk reflects on the outcomes that went on to be published in Nature Biotechnology.

The original article can be found on Biovox and is republished here with kind permission.

Read More

Translating Microbiome Futures

In May of this year, Nature Biotechnology and Global Engage convened a panel of leaders in the microbiome field that included CEOs and CSOs of several microbiome companies, representatives from big pharmas working in the space, and top academics from the New York area and beyond to discuss the current state of the art in human microbiome research and its translation into therapies.

Read More

Charting a Translational Roadmap in the Microbiome Space – A Multidimensional Challenge

The opportunity afforded by the microbiome for developing therapeutic and wellness products is matched only by the formidable task of unraveling the science of the microbiome in the first place. Microbiome research is transitioning from a descriptive to a more mechanistic science, and progress in understanding mechanisms that underpin microbiome biology is likely to result in a surge of interest in this space on the part of the biotech, pharma and investor communities.

Read More

Looking beyond the bacterial gut microbiome

Most microbiome research to date has focused on the bacterial gut microbiome, and yet microbiomes are comprised of a wide array of microbes – from viruses and archaea to protozoa and yeasts – and colonize nearly every human body site – from the skin and lungs to the urogenital system and breast milk.

Read More

The conundrum with animal models of the human microbiome

The most that can be expected from any model is that it can supply a useful approximation to reality: All models are wrong; some models are useful.

This aphorism, simply articulated here by prominent British statistician George Box, gets to the crux of the dilemma we face when considering animal models for the study of human microbiome dynamics and mechanisms.

Read More

Collaboration, Translation and the Future of Microbiome Innovation

Translation. When we hear this word, it may evoke feelings of excitement, adventure and possibility that come with learning different languages or travelling to a foreign country. For scientists, ‘translation’ also suggests moving research findings from the laboratory into clinical practice. Just as words are translated, so too are research findings.

Read More

Investing in the microbiome – a look back into the future

With 2017 now in the rear-mirror, it is a good time to assess the investment landscape in the microbiome space and try to identify relevant trends indicative of where microbiome science and the industry might be headed next. To do this I contacted Matt Martin, Microbiome Innovation and Ventures Lead at the University of Chicago. Matt has been analyzing the space for some time now, and in collaboration with Michael Lohmeier, a student at the Tepper School of Business, Carnegie Mellon University, has kept a tab on companies and investors alike.

Read More

Microbiome-based interventions – a labyrinth of modalities

Microbiome-based interventions, whether therapeutic or prophylactic, come in a broad spectrum of modalities, a consequence of the complexity of and possibilities afforded by the microbiome.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Archive